Listed below are the charts and positions for Prevnar 13 / Prevenar 13 / Prevnar 20 / Apexxnar in this year’s pharmaceutical sales data alongside recent articles on PMLiVE featuring Prevnar 13 / ...

It covers 15 different pneumococcal serotypes – two more than Pfizer's current Prevnar 13 shot – and has been approved for use in patients aged 18 or over. Pfizer's updated 20-valent vaccine ...

The Prevnar 20 approval comes a few weeks ahead of an FDA decision on Merck's V114, which was granted a priority review by the regulator in January for the prevention of IPD in adults.

[PFIZER KOREA] Pfizer aims to release its latest pneumococcal vaccine, Prevnar 20, early next year in Korea. Prevnar, suitable for all individuals six weeks and older, offers protection against ...